SynBioBeta Speaker
Clayton Rabideau
CEO
Syntensor Incorporated
Clayton is the founder of Syntensor, a startup that develops frontier models for drug development and human genetics with a particular focus on predicting the underlying drivers of clinical trial outcomes and trait prediction from human genomes."
SynBioBeta 2025 - Session Speaker
